Utah Medical Products Inc

Utah Medical Products Inc(UTMD)股票分析

$72.210

+2.260 (+3.13%)收盤時

Loading chart…
最高
73.350
開盤
70.590
成交量加權均價
72.05
成交量
51.33K
市值
235.88M
最低
70.590
成交金額
3.70M
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Utah Medical Products, Inc. manufactures and markets a range of specialty medical devices. The Company’s range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians offices. Its products are sold directly to end-user facilities in the United States, Ireland, United Kingdom, Canada, France and Australia, and through third party distributors in other outside the United States (OUS) markets. It offers fetal monitoring accessories. Its specialized labour and delivery tools include BT-Cath, CVX-Ripe, AROM-COT, MUC-X, and Cordguard. The Company’s vacuum-assisted delivery (VAD) systems include CMI soft silicone bell-shaped birthing cups and reusable hand-held vacuum pumps, which are the safest products available for use in vacuum-assisted operative deliveries. Its neonatal intensive care products include Disposa-Hood and GESCO. It also distributes harm-reduction medical devices.

AI 分析 of Utah Medical Products Inc (UTMD)

持有

Utah Medical Products is currently a hold. The stock is trading at $70.55, which is 72.7% of its 52-week range, indicating it is closer to its high than its low. The forward P/E ratio is 13.04, suggesting it is reasonably valued compared to its earnings potential. However, the RSI is at 44.47, indicating it is not yet oversold, and the recent 5-day change of -4.04% shows a downward trend that may continue in the short term.

估值指標

Utah Medical Products Inc(UTMD)目前預期本益比為 13.04,5 年平均預期本益比為 2.21。

預期本益比

嚴重高估
5 年均值 P/E
2.21
目前P/E
13.04
高估
7.12
低估
-2.69

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
0.00
目前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 對 UTMD 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%UTMD

$61.55

情境價格

基

基準

基準 · 50%UTMD

$52.40

情境價格

悲

悲觀

悲觀 · 25%UTMD

$44.83

情境價格

事件時間軸

2026-11-03 (ET)

10:30:00

Utah Medical Products Announces Quarterly Cash Dividend of $0.315

2026-10-29 (ET)

09:00:00

Utah Medical Products to Repurchase Up to 650,000 Shares at $75 Each

2026-10-22 (ET)

09:30:00

Company Reports Revenue of $8.6M, Down from $9.8M Last Year

2026-10-05 (ET)

09:00:00

Utah Medical Products Extends Stock Buyback to October 27

2026-09-24 (ET)

17:00:00

Utah Medical Products to Buy Back 650,000 Shares at $75 Each

資訊

UTMD 常見問題 —— 由 Alphio AI 解答

Utah Medical Products, Inc. manufactures and markets a range of specialty medical devices. The Company’s range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians offices. Its products are sold directly to end-user facilities in the United States, Ireland, United Kingdom, Canada, France and Australia, and through third party distributors in other outside the United States (OUS) markets. It offers fetal monitoring accessories. Its specialized labour and delivery tools include BT-Cath, CVX-Ripe, AROM-COT, MUC-X, and Cordguard. The Company’s vacuum-assisted delivery (VAD) systems include CMI soft silicone bell-shaped birthing cups and reusable hand-held vacuum pumps, which are the safest products available for use in vacuum-assisted operative deliveries. Its neonatal intensive care products include Disposa-Hood and GESCO. It also distributes harm-reduction medical devices. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Utah Medical Products is currently a hold. The stock is trading at $70.55, which is 72.7% of its 52-week range, indicating it is closer to its high than its low. The forward P/E ratio is 13.04, suggesting it is reasonably valued compared to its earnings potential. However, the RSI is at 44.47, indicating it is not yet oversold, and the recent 5-day change of -4.04% shows a downward trend that may continue in the short term.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易